ストックスクリーナーアプリを入手
3.60
0.56%
0.02
前日終値:
$3.58
開ける：
$3.63
24時間の取引高:
144.40K
Relative Volume:
0.05
時価総額：
$44.30M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+4.65%
1か月 パフォーマンス:
+11.11%
6か月 パフォーマンス:
+138.41%
1年 パフォーマンス:
+10.09%
1日の値動き範囲:
$3.48
$3.7299
1週間の範囲:
$3.22
$3.77
52週間の値動き範囲:
$1.345
$6.3699
Q 32 Bio Inc Stock (QTTB) Company Profile
QTTB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
3.60 | 44.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-11 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | BMO Capital Markets | Outperform |
| 2024-10-24 | 開始されました | Raymond James | Strong Buy |
| 2024-09-11 | 開始されました | Wells Fargo | Overweight |
| 2024-06-17 | 開始されました | Guggenheim | Buy |
| 2024-05-21 | 開始されました | Leerink Partners | Outperform |
| 2024-04-11 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Piper Sandler | Overweight |
| 2023-07-28 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | 繰り返されました | BTIG Research | Neutral |
| 2022-02-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-02-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2020-12-14 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Buy |
| 2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-24 | 開始されました | Chardan Capital Markets | Buy |
| 2019-11-01 | 開始されました | Oppenheimer | Perform |
| 2019-09-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Q 32 Bio Inc (QTTB) 最新ニュース
How Q32 Bio Inc. stock benefits from global expansionRecession Risk & Reliable Volume Spike Trade Alerts - ulpravda.ru
Is Q32 Bio Inc. stock attractive after correctionJuly 2025 Trends & Weekly Consistent Profit Watchlists - ulpravda.ru
Will Q32 Bio Inc. stock deliver better than expected guidanceJuly 2025 Reactions & Entry and Exit Point Strategies - ulpravda.ru
Can Q32 Bio Inc. stock attract ESG capital inflowsQuarterly Market Review & Detailed Earnings Play Strategies - ulpravda.ru
Will Q32 Bio Inc. stock maintain momentum in 2025Market Trend Review & AI Based Trade Execution Alerts - ulpravda.ru
Aug Gainers: How Q32 Bio Inc. stock benefits from global expansion2025 Top Decliners & AI Driven Stock Movement Reports - ulpravda.ru
Portfolio Recap: Will Q32 Bio Inc. stock maintain momentum in 2025July 2025 Drop Watch & Breakout Confirmation Alerts - ulpravda.ru
Why retail investors pile into Q32 Bio Inc. stock2026 world cup usa national team round of 16 midfield engines high defensive line group prediction breakdown - ulpravda.ru
Form 8K Q32 Bio Inc For: 19 December - Investing.com
Fundamentals Check: Will Q32 Bio Inc stock gain from lower inflationWatch List & Consistent Profit Trading Strategies - moha.gov.vn
Q32 Bio Retains Mark Iwicki as Board Chair - The Globe and Mail
Q32 Bio director Mark Iwicki withdraws resignation and will remain board chair - Investing.com
How Q32 Bio Inc. stock trades before earningsWeekly Trading Summary & Real-Time Buy Signal Alerts - DonanımHaber
Why Q32 Bio Inc. stock remains on watchlistsJuly 2025 EndofMonth & Reliable Price Breakout Signals - DonanımHaber
Will Q32 Bio Inc. stock gain from lower inflationNew Guidance & Safe Entry Momentum Stock Tips - DonanımHaber
Can Q32 Bio Inc. stock deliver strong Q4 earningsMarket Trend Review & Breakout Confirmation Alerts - DonanımHaber
Q32 Bio Inc.(NasdaqCM: QTTB) dropped from NASDAQ Biotechnology Index - marketscreener.com
Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target - Investing.com
Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia - MSN
Will Q32 Bio Inc stock gain from lower inflationWeekly Gains Summary & Fast Moving Market Watchlists - moha.gov.vn
Aug Technicals: Can Q32 Bio Inc stock attract ESG capital inflowsQuarterly Profit Review & Verified Momentum Stock Ideas - moha.gov.vn
Q32 Bio Insiders Benefit From Selling Stock At US$2.86 - simplywall.st
Stock Market Recap: Why millennials buy Spire Inc LGR stockInsider Buying & Safe Swing Trade Setups - BỘ NỘI VỤ
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Q32 Bio Inc. stock a defensive play in 2025Quarterly Profit Report & Accurate Technical Buy Alerts - Newser
Lee Kalowski, Q32 Bio CFO, sells $31k in shares By Investing.com - Investing.com UK
Is Q32 Bio Inc. stock recession proofWeekly Profit Report & Technical Analysis for Trade Confirmation - Newser
Q32 Bio CEO Morrison sells $77870 in stock By Investing.com - Investing.com South Africa
Insider Sell: Lee Kalowski Sells Shares of Q32 Bio Inc (QTTB) - GuruFocus
Lee Kalowski, Q32 Bio CFO, sells $31k in shares - Investing.com
CEO Morrison Sells 22,506 ($77.9K) Of Q32 Bio Inc [QTTB] - TradingView
Synopsys, Moderna, Strategy, Q32 Bio, Wolfspeed: Stocks Making The Biggest Moves Today - MSN
Deal Watch: Akebia Gets Phase II Alopecia Areata Candidate From Cost-Conscious Q32 - Citeline News & Insights
Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M - MSN
QTTB Stock Faces Volatile Swings Amid Market Turmoil - timothysykes.com
Nothing is Better Than Q32 Bio Inc (QTTB) stock at the moment - Setenews
Block Trades: Will CGEN stock remain a Wall Street favorite2025 Technical Overview & Consistent Profit Alerts - BỘ NỘI VỤ
QTTB Stock Explodes Nearly 95%: Akebia Deal Transforms Q32 Bio’s Future - Bitget
Q32 Bio (QTTB) Stock Analysis Report | Financials & Insights - Benzinga
Will Q32 Bio Inc. stock attract ESG investorsTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook - ts2.tech
Q32 Bio Sells Complement Inhibitor ADX-097 - citybiz
Q 32 Bio Inc (QTTB) 財務データ
Q 32 Bio Inc (QTTB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Q 32 Bio Inc (QTTB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kalowski Lee | CFO and President |
Dec 02 '25 |
Sale |
3.46 |
9,072 |
31,395 |
39,938 |
0.90%
大文字化:
|
ボリューム (24 時間):